Medicare AdvantageCoverageMedium impact
MA00.004b, Routine Costs of Clinical Trials and Coverage of Investigational Devices A and B
Independence Blue Cross·Oncology, Cardiology, Neurology +2 more·Medical Policy
Effective date
Nov 26, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA00.004b regarding routine costs of clinical trials and investigational devices A and B has been reissued with an effective date of November 26, 2025. This appears to be a policy reissuance rather than substantive changes, but billing teams should review the full policy details when available.
Action Required
By November 26, 2025: Billing team should access the full policy at the provided URL to review any changes to clinical trial billing procedures and investigational device coverage requirements. Update billing workflows if the full policy contains new requirements for clinical trial cost coverage or device authorization processes.